Learn More About Houston Beneficiary, MD Anderson!

June 18, 2019

We are excited to have MD Anderson Brain and Spine Center as our beneficiary again for our 7th Annual Head for the Cure 5K- Houston on October 12th! Learn more about the institute, clinic, and their current clinical trials! Don't forget you can register or donate today at headforthecure.org/houston.

About MD Anderson
The University of Texas MD Anderson Cancer Center is one of the world's most respected centers devoted exclusively to cancer patient care, research, education and prevention. It is located in central Houston in the Texas Medical Center. MD Anderson was created in 1941 as part of The University of Texas System. The institution is one of the nation’s original three comprehensive cancer centers designated by the National Cancer Act of 1971 and is one of 47 National Cancer Institute-designated comprehensive cancer centers today. Learn more about MD Anderson.

About the Brain and Spine Center
The Anne C. Brooks Brain and Spine Center at MD Anderson is one of the largest programs of its kind in the country. Our multidisciplinary team includes more than two dozen neuro-oncologists, neurosurgeons and radiation oncologists who specialize in treating both malignant and benign tumors of the central nervous system, including the brain, spine and skull base. Learn more about the Brain and Spine Center.

Brain Tumor Research at MD Anderson
The Brain Tumor Research Program at MD Anderson is a multidisciplinary program that spans 22 departments and involves more than 100 research and clinical scientists who focus on discovering the molecular changes that drive brain tumors and developing effective new treatments. 

MD Anderson has recently opened three brain tumor clinical trials: 

  • Phase II: GDC-0084 for newly diagnosed MGMT unmethylated glioblastoma
  • Phase I: Allogenic bone marrow human mesenchymal stem cells loaded with DNX-2401 for recurrent glioblastoma
  • Phase II: ONC201 for recurrent high-grade gliomas with H3 K27M mutation

Find out more at www.mdanderson.org/neuroclinicaltrials.